Dentists are warning about the side effects of using GLP-1 medications, referred to as "Ozempic teeth," which can lead to oral health problems such as cavities, enamel erosion, and dry mouth. #zdrowie #dentystyka #Ozempic (translated)

Dentists are warning about the side effects of using GLP-1 medications, referred to as "Ozempic teeth," which can lead to oral health problems such as cavities, enamel erosion, and dry mouth. #zdrowie #dentystyka #Ozempic (translated)

The author wrote that he initially assumed the video was fake. According to his account, however, the montage showed genuine footage and photos of thin Hollywood stars. He pointed out that numerous celebrities had publicly admitted to taking GLP-1 medications such as Ozempic, Wegovy, or Mounjaro, including Oprah and Serena. (translated)
The FDA has ordered manufacturers of drugs containing GLP-1 receptor agonists to include warnings about the risk of developing anterior ischemic optic neuropathy, a condition that can lead to vision loss, although experts maintain that the benefits of these drugs continue to outweigh the potential risks. #FDA #semaglutida #obesidad (translated)

China has authorized the marketing of the first oral GLP-1 pill for weight loss, aimed at adults with excess weight who have at least one weight-related disease, opening new opportunities in the obesity treatment market. #Obesidade #Saúde #China (translated)

The increasing use of injectable weight-loss medications, such as GLP-1, requires medical guidance due to health risks, dietary pitfalls, and the need for proper nutrition and exercise. #Αδυνάτισμα #Υγεία #Διατροφή (translated)
Eli Lilly becomes the first American lab to obtain approval in China for a weight loss pill based on GLP-1, thus gaining an advantage over its competitor Novo Nordisk in the obesity market. #EliLilly #GLP1 #Obésité (translated)

The FDA has required drug manufacturers such as Ozempic to modify their labels to include warnings about a low risk of non-arteritic anterior ischemic optic neuropathy in patients using GLP-1 agonists for diabetes and obesity. #Ozempic #Diabetes #Salud (translated)

The U.S. Food and Drug Administration (FDA) is issuing a warning on GLP-1 medications, such as Ozempic and Wegovy, due to the risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), which can lead to sudden and permanent vision loss in one eye. #NAION #zdrowie #cukrzyca (translated)
GLP-1 drugs, initially designed to treat type 2 diabetes and obesity, show promise in reducing the severity of psoriasis, although more research is needed to confirm their efficacy and safety in this context. #Psoriasis #GLP1 #Salud (translated)

A study with over 80,000 patients with type 2 diabetes shows that discontinuing GLP-1 medications significantly increases the risk of heart attacks, strokes, and increased mortality. #Typ2Diabetes #Herzgesundheit #GLP1Medikamente (translated)
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION. #GLP1Drugs #EyeHealth #FDAWarnings

The FDA issued a warning about GLP-1 medications, such as Ozempic and Wegovy, due to a possible increase in the risk of NAION, a rare ophthalmological condition that can lead to vision loss, although a causal relationship has not been established. #ΔημόσιαΥγεία #Ozempic #NAION (translated)
The American Food and Drug Administration (FDA) has issued new warnings for GLP-1 class medications, including Ozempic, due to the risk of a rare but serious eye disease that can cause vision loss. #Ozempic #NAION #lijekovizamršavljenje (translated)
The author wrote that GLP-1 medications for obesity apparently also improve knee osteoarthritis independently of weight loss by reducing inflammation in the knee. This would make movement and sports possible again. He expressed hope that prices would drop soon. #Gesundheit #Arthrose #Gewichtsreduktion #DE (translated)
Nutritionist María José Crispín warns that the treatment with GLP-1 medications for obesity should focus on a long-term approach and the personalization of the dosage, avoiding the obsession with rapid weight loss. #GLP1 #PérdidaDePeso #Nutrición (translated)

The discontinuation of GLP-1 medications, such as Ozempic and Mounjaro, may negate the significant cardiovascular benefits they offer, highlighting the risk of heart attack and stroke in individuals who discontinue them. #Ozempic #Mounjaro #Υγεία (translated)

Novo Nordisk has launched Wegovy in Spain, the first oral GLP-1 receptor agonist for weight control, which, along with lifestyle changes, can achieve weight loss of 17%, consolidating its importance in the growing market for obesity medications. #Obesidad #Wegovy #Salud (translated)

The author noted that a new study found a link between GLP-1 medications and fewer hospitalizations in individuals with schizophrenia, while experts called for caution in interpreting the findings. https://t.co/w6QOwrItzt #υγεία #παθήσεις #φάρμακα #GR (translated)
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us". #WeightLoss #BeautyIndustry #Skincare

Heineken warns British pubs of a decline in sales due to the increasing use of GLP-1 preparations, which increase feelings of fullness and reduce cravings for alcohol. #Heineken #Pubs #Alkoholkonsum (translated)
